Metallic ureteral stents: A cost-effective method of managing benign upper tract obstruction

Journal of Endourology

Volumn 24, Issue 3, 2010, Pages 483-485

  López Huertas, Héctor L ^a   Polcari, Anthony J ^a   Acosta Miranda, Alex ^b   Turk, Thomas M T ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; METAL; POLYMER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEMATURIA; HUMAN; MICTURITION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; URETER STENT; URINARY TRACT; URINARY TRACT OBSTRUCTION;

ADULT; AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; HUMANS; METALS; MIDDLE AGED; STENTS; URETER; URETERAL OBSTRUCTION;

EID: 77950124235     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2009.0192     Document Type: Article

References (11)

1. Wolf SJ. The undoing of ureteral obstruction from malignancy-who and how? J Urol 2008;180:435-436.
2. Wah TM, Irving HC, Cartledge J. Initial experience with the resonance metallic stent for antegrade ureteric stenting. Cardiovasc Intervent Radiol 2007;30:705-710.
3. Kouba E, Wallen EM, Pruthi EM. Management of ureteral obstruction due to advanced malignancy: Optimizing therapeutic and palliative outcomes. J Urol 2008;180:444-450.
4. Eyre RC, Benotti PN, Bothe A, Cady B, Steele G Jr. Management of the urinary tract involved by recurrent cancer. Arch Surg 1987;122:493-498.
5. Ku JH, Lee SW, Jeon HG, Kim HH, Oh SJ. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: Are there differences? Urology 2004;64:895-899.
6. Radecka E, Magnusson M, Magnusson A. Survival time and period of catheterization in patients treated with percutaneous nephrostomy for urinary obstruction due to malignancy. Acta Radiol 2006;47:328-331.
7. Wong LM, Cleeve LK, Milner AD, Pitman AG. Malignant ureteral obstruction:Outcomes after intervention.Have things changed? J Urol 2007;178:178-183.
8. Rosevear HM, Kim SP, Wenzler DL, Faerber GJ, Roberts WW, Wolf JS Jr. Retrograde ureteral stents for extrinsic ureteral obstruction: Nine years' experience at University of Michigan. Urology 2007;70:846-850.
9. Blaschko SD, Deane LA, Krebs A, et al. In-vivo evaluation of flow characteristics of novel metal ureteral stent. J Endourol 2007;21:780-783.
10. Christman MS, L'esperance JO, Choe CH, Stroup SP, Auge BK. Analysis of ureteral stent compression force and its role in malignant obstruction. J Urol 2009;181:392-396.
11. Joshi HB, Chitale SV, Nagarajan M, Irving SO, Browning AJ, Biyani CS, Burgess NA. A prospective randomized singleblind comparison of ureteral stents composed of firm and soft polymer. J Urol 200;174:2303-2306.